Biotecnología
Biotecnología
Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy
22/07/2021 -
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
Vetter’s New Clinical Mfg. Site Now Fully Integrated
22/07/2021 -
Expands clinical capacity to address growing market demand.
AskBio’s Gene Therapy Gets Fast Track
22/07/2021 -
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
Japan First to Approve Roche’s Ronapreve to Treat COVID-19
22/07/2021 -
Full approval is based on a global phase III trial which found casirivimab and imdevimab reduced hospitalization or death by 70%.
TCR2 Therapeutics Appoints Chief Technical Officer
22/07/2021 -
Peter Olagunju to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs.
Aptar CSP’s Activ-Film Technology Protects COVID-19 Tests
22/07/2021 -
Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization from the FDA.
Thermo Fisher Scientific Launches Heracell Vios CR CO2 Incubator
22/07/2021 -
First-in-market CO2 incubator combines optimal cell growth capabilities with certified cleanroom compatibility.
MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development
22/07/2021 -
Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.
Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa
22/07/2021 -
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.
Idifarma Launches Accelerated Pathway for Complex Drugs
21/07/2021 -
‘Simply to Clinic’ leverages expertise in oral standard and highly potent drugs to take projects from pre-formulation to clinical trials.
Eisai, Biogen’s Lecanemab Gets Breakthrough Designation in AD
21/07/2021 -
Based on pre-specified analysis showing consistent reduction of clinical decline across several clinical and biomarker endpoints at the highest doses.
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
21/07/2021 -
Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.
ExeVir, Mithra CDMO Enter Manufacturing Collaboration
21/07/2021 -
Manufacturing of ExeVir's candidate product for Covid-19 Treatments will take place at Mithra CDMO's new injectable facility.
CRO Charnwood Molecular Expands Capabilities
21/07/2021 -
$75m construction project in Loughborough creates flexible facility for the growing CRO.
Evergreen Expands Alpha Radiopharmaceutical Production Capabilities
21/07/2021 -
A GMP state-of-the-art alpha emitter production center will be integrated into Evergreen’s existing facility.
Vibalogics Advances Growth with Leadership Hires
21/07/2021 -
Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
21/07/2021 -
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.
Curtana and Catalent Enter Brain Cancer Drug Partnership
21/07/2021 -
Sign development and manufacturing agreement for brain cancer drug CT-179.
ImmVira Launches Pilot-scale Production Line
21/07/2021 -
To expedite the advancement of next-generation oncolytic virus clinical trials.
Recipharm Invests in Fill Finish Capacity
21/07/2021 -
New facility in Uttarakhand, India will increase capacity to 1 billion sterile units per year.
Samsung Biologics, Kineta Enter Development and Manufacturing Agreement
21/07/2021 -
Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.
